If you've taken a MyHeritage DNA test for ancestry, your raw data file already contains the genetic variants that determine how your body processes dozens of common medications. MyHeritage doesn't offer a pharmacogenetic report directly, but the information is sitting in your account waiting to be analyzed. You just need to download the raw data and upload it to a service that can interpret the drug-metabolism variants.
A pharmacogenetic report generated from MyHeritage data is informational and does not replace medical advice. Do not change or stop any medication based on genetic results alone. Always discuss findings with your doctor or pharmacist before making treatment decisions.
MyHeritage uses a genotyping chip that captures hundreds of thousands of SNPs across your genome, including many of the variants that define clinical pharmacogenetic phenotypes. Genes like CYP2D6, CYP2C19, CYP2C9, SLCO1B1, and VKORC1 — the workhorses of pharmacogenomics — are all represented in the raw data.
MyHeritage lets you download your raw DNA data from your DNA settings page as a compressed ZIP file. Inside is a tab-separated text file with your genotype at every position MyHeritage tested. That file is all Gene2Rx needs to generate a full pharmacogenetic report.
A dedicated clinical pharmacogenetic test typically means ordering a new kit, providing a new saliva or cheek swab sample, and waiting weeks for lab processing. If you already have MyHeritage data, none of that applies. The analysis is digital — your report is ready in minutes.
Commercial pharmacogenetic panels run from several hundred to over a thousand dollars. Turning your existing MyHeritage data into a pharmacogenetic report costs a small fraction of that, because the lab work has already been done and paid for. You're unlocking value from genetic data you already own.
Here's what a pharmacogenetic analysis of your MyHeritage data typically surfaces.
Metabolizes antidepressants (paroxetine, venlafaxine, fluoxetine, amitriptyline), pain medications (codeine, tramadol), the ADHD medication atomoxetine, the breast cancer drug tamoxifen, and beta-blockers like metoprolol. Roughly 5-10% of people are poor metabolizers and respond atypically to these drugs.
Determines response to SSRIs (sertraline, escitalopram, citalopram), the blood thinner clopidogrel, and proton pump inhibitors like omeprazole. About 30% of people carry variants that meaningfully change drug exposure.
Paired with VKORC1 for warfarin dosing, and also affects NSAIDs (celecoxib, meloxicam, ibuprofen) and phenytoin. Variants can increase bleeding risk with warfarin or side effect risk with NSAIDs.
Drives statin-associated muscle pain risk, particularly with simvastatin and atorvastatin. About 15-20% of people carry the higher-risk variant.
Affects warfarin sensitivity. Combined with CYP2C9, it helps predict an individualized starting dose instead of the standard trial-and-error approach.
Your MyHeritage raw data contains the genotype calls needed to assign you a metabolizer phenotype (poor, intermediate, normal, rapid, ultrarapid) for each of these genes. A proper pharmacogenetic report translates those phenotypes into concrete, drug-by-drug recommendations based on published CPIC and FDA guidelines.
If you already have MyHeritage data, converting it into a pharmacogenetic report is low-effort and long-lasting — your DNA does not change, so a one-time analysis is useful for every future prescription. It is especially valuable if you are starting a new medication with known PGx guidelines, if you have had unexplained side effects or non-response, or if you simply want the information on file for any future prescribing decisions.
Learn how genetics may affect your response to these related medications:
MyHeritage's own health reports focus on hereditary disease risk rather than drug response, and they do not include a comprehensive pharmacogenetic report. The pharmacogenetic variants are in your raw data, but MyHeritage doesn't interpret them for medication recommendations.
MyHeritage uses a clinical-grade genotyping array that reliably captures the common pharmacogenetic variants used in CPIC and FDA guidelines. While no genotyping chip sees every rare variant, the platform covers the key SNPs that drive the majority of clinically actionable PGx recommendations.
A Gene2Rx pharmacogenetic report is typically generated within a few minutes of upload. You'll receive an email when the report is ready to view in your account.
Yes. Your DNA does not change over time, and MyHeritage's chip versions have consistently covered the core pharmacogenetic variants. Older exports are just as usable as recent ones.
Find out how your DNA may influence your response to Sertraline and other medications with a Gene2Rx pharmacogenetics report.
Get Your Report Try Our Free Calculator